124 related articles for article (PubMed ID: 38744376)
1. Effect of tocilizumab plus corticosteroid on clinical outcome in patients hospitalized with severe fever with thrombocytopenia syndrome: A randomized clinical trial.
Ge HH; Cui N; Yin XH; Hu LF; Wang ZY; Yuan YM; Yue M; Lv HD; Wang Z; Zhang WW; Zhang L; Yuan L; Fan XJ; Yang X; Wu YX; Si GQ; Hu ZY; Li H; Zhang XA; Bao PT; Liu W
J Infect; 2024 Jul; 89(1):106181. PubMed ID: 38744376
[TBL] [Abstract][Full Text] [Related]
2. Corticosteroids May Have Negative Effects on the Management of Patients with Severe Fever with Thrombocytopenia Syndrome: A Case-Control Study.
Kawaguchi T; Umekita K; Yamanaka A; Hara S; Yamaguchi T; Inoue E; Okayama A
Viruses; 2021 Apr; 13(5):. PubMed ID: 33925061
[TBL] [Abstract][Full Text] [Related]
3. Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia: A Randomized Clinical Trial.
Hermine O; Mariette X; Tharaux PL; Resche-Rigon M; Porcher R; Ravaud P;
JAMA Intern Med; 2021 Jan; 181(1):32-40. PubMed ID: 33080017
[TBL] [Abstract][Full Text] [Related]
4. Real-life use of tocilizumab with or without corticosteroid in hospitalized patients with moderate-to-severe COVID-19 pneumonia: A retrospective cohort study.
Russo G; Solimini A; Zuccalà P; Zingaropoli MA; Carraro A; Pasculli P; Perri V; Marocco R; Kertusha B; Del Borgo C; Del Giudice E; Fondaco L; Tieghi T; D'Agostino C; Oliva A; Vullo V; Ciardi MR; Mastroianni CM; Lichtner M
PLoS One; 2021; 16(9):e0257376. PubMed ID: 34506608
[TBL] [Abstract][Full Text] [Related]
5. Ruxolitinib plus standard of care in severe hospitalized adults with severe fever with thrombocytopenia syndrome (SFTS): an exploratory, single-arm trial.
Wen S; Xu N; Zhao L; Yang L; Yang H; Chang C; Wang S; Qu C; Song L; Zou W; He Y; Wang G
BMC Med; 2024 May; 22(1):204. PubMed ID: 38764059
[TBL] [Abstract][Full Text] [Related]
6. Clinical effect and antiviral mechanism of T-705 in treating severe fever with thrombocytopenia syndrome.
Li H; Jiang XM; Cui N; Yuan C; Zhang SF; Lu QB; Yang ZD; Xin QL; Song YB; Zhang XA; Liu HZ; Du J; Fan XJ; Yuan L; Yuan YM; Wang Z; Wang J; Zhang L; Zhang DN; Wang ZB; Dai K; Bai JY; Hao ZN; Fan H; Fang LQ; Xiao G; Yang Y; Peng K; Wang HQ; Li JX; Zhang LK; Liu W
Signal Transduct Target Ther; 2021 Apr; 6(1):145. PubMed ID: 33859168
[TBL] [Abstract][Full Text] [Related]
7. Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial.
Maes B; Bosteels C; De Leeuw E; Declercq J; Van Damme K; Delporte A; Demeyere B; Vermeersch S; Vuylsteke M; Willaert J; Bollé L; Vanbiervliet Y; Decuypere J; Libeer F; Vandecasteele S; Peene I; Lambrecht B
Trials; 2020 Jun; 21(1):468. PubMed ID: 32493441
[TBL] [Abstract][Full Text] [Related]
8. Comparative Survival Analysis of Immunomodulatory Therapy for Coronavirus Disease 2019 Cytokine Storm.
Narain S; Stefanov DG; Chau AS; Weber AG; Marder G; Kaplan B; Malhotra P; Bloom O; Liu A; Lesser ML; Hajizadeh N;
Chest; 2021 Mar; 159(3):933-948. PubMed ID: 33075378
[TBL] [Abstract][Full Text] [Related]
9. Low-Dose Tocilizumab With High-Dose Corticosteroids in Patients Hospitalized for COVID-19 Hypoxic Respiratory Failure Improves Mortality Without Increased Infection Risk.
Brosnahan SB; Chen XJC; Chung J; Altshuler D; Islam S; Thomas SV; Winner MD; Greco AA; Divers J; Spiegler P; Sterman DH; Parnia S
Ann Pharmacother; 2022 Mar; 56(3):237-244. PubMed ID: 34180274
[TBL] [Abstract][Full Text] [Related]
10. Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19).
Rodríguez-Baño J; Pachón J; Carratalà J; Ryan P; Jarrín I; Yllescas M; Arribas JR; Berenguer J; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
Clin Microbiol Infect; 2021 Feb; 27(2):244-252. PubMed ID: 32860964
[TBL] [Abstract][Full Text] [Related]
11. Tocilizumab improves 28-day survival in hospitalized patients with severe COVID-19: an open label, prospective study.
Karampitsakos T; Malakounidou E; Papaioannou O; Dimakopoulou V; Zarkadi E; Katsaras M; Tsiri P; Tsirikos G; Georgiopoulou V; Oikonomou I; Davoulos C; Velissaris D; Sampsonas F; Marangos M; Akinosoglou K; Tzouvelekis A
Respir Res; 2021 Dec; 22(1):317. PubMed ID: 34937570
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Tocilizumab in Patients Hospitalized with Covid-19.
Stone JH; Frigault MJ; Serling-Boyd NJ; Fernandes AD; Harvey L; Foulkes AS; Horick NK; Healy BC; Shah R; Bensaci AM; Woolley AE; Nikiforow S; Lin N; Sagar M; Schrager H; Huckins DS; Axelrod M; Pincus MD; Fleisher J; Sacks CA; Dougan M; North CM; Halvorsen YD; Thurber TK; Dagher Z; Scherer A; Wallwork RS; Kim AY; Schoenfeld S; Sen P; Neilan TG; Perugino CA; Unizony SH; Collier DS; Matza MA; Yinh JM; Bowman KA; Meyerowitz E; Zafar A; Drobni ZD; Bolster MB; Kohler M; D'Silva KM; Dau J; Lockwood MM; Cubbison C; Weber BN; Mansour MK;
N Engl J Med; 2020 Dec; 383(24):2333-2344. PubMed ID: 33085857
[TBL] [Abstract][Full Text] [Related]
13. Clinical efficacy and safety evaluation of favipiravir in treating patients with severe fever with thrombocytopenia syndrome.
Yuan Y; Lu QB; Yao WS; Zhao J; Zhang XA; Cui N; Yuan C; Yang T; Peng XF; Lv SM; Li JC; Song YB; Zhang DN; Fang LQ; Wang HQ; Li H; Liu W
EBioMedicine; 2021 Oct; 72():103591. PubMed ID: 34563924
[TBL] [Abstract][Full Text] [Related]
14. Epidemiological and clinical features of laboratory-diagnosed severe fever with thrombocytopenia syndrome in China, 2011-17: a prospective observational study.
Li H; Lu QB; Xing B; Zhang SF; Liu K; Du J; Li XK; Cui N; Yang ZD; Wang LY; Hu JG; Cao WC; Liu W
Lancet Infect Dis; 2018 Oct; 18(10):1127-1137. PubMed ID: 30054190
[TBL] [Abstract][Full Text] [Related]
15. Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial.
Salvarani C; Dolci G; Massari M; Merlo DF; Cavuto S; Savoldi L; Bruzzi P; Boni F; Braglia L; Turrà C; Ballerini PF; Sciascia R; Zammarchi L; Para O; Scotton PG; Inojosa WO; Ravagnani V; Salerno ND; Sainaghi PP; Brignone A; Codeluppi M; Teopompi E; Milesi M; Bertomoro P; Claudio N; Salio M; Falcone M; Cenderello G; Donghi L; Del Bono V; Colombelli PL; Angheben A; Passaro A; Secondo G; Pascale R; Piazza I; Facciolongo N; Costantini M;
JAMA Intern Med; 2021 Jan; 181(1):24-31. PubMed ID: 33080005
[TBL] [Abstract][Full Text] [Related]
16. Tocilizumab plus standard care versus standard care in patients in India with moderate to severe COVID-19-associated cytokine release syndrome (COVINTOC): an open-label, multicentre, randomised, controlled, phase 3 trial.
Soin AS; Kumar K; Choudhary NS; Sharma P; Mehta Y; Kataria S; Govil D; Deswal V; Chaudhry D; Singh PK; Gupta A; Agarwal V; Kumar S; Sangle SA; Chawla R; Narreddy S; Pandit R; Mishra V; Goel M; Ramanan AV
Lancet Respir Med; 2021 May; 9(5):511-521. PubMed ID: 33676589
[TBL] [Abstract][Full Text] [Related]
17. Case-fatality ratio and effectiveness of ribavirin therapy among hospitalized patients in china who had severe fever with thrombocytopenia syndrome.
Liu W; Lu QB; Cui N; Li H; Wang LY; Liu K; Yang ZD; Wang BJ; Wang HY; Zhang YY; Zhuang L; Hu CY; Yuan C; Fan XJ; Wang Z; Zhang L; Zhang XA; Walker DH; Cao WC
Clin Infect Dis; 2013 Nov; 57(9):1292-9. PubMed ID: 23965284
[TBL] [Abstract][Full Text] [Related]
18. Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia.
Rosas IO; Bräu N; Waters M; Go RC; Hunter BD; Bhagani S; Skiest D; Aziz MS; Cooper N; Douglas IS; Savic S; Youngstein T; Del Sorbo L; Cubillo Gracian A; De La Zerda DJ; Ustianowski A; Bao M; Dimonaco S; Graham E; Matharu B; Spotswood H; Tsai L; Malhotra A
N Engl J Med; 2021 Apr; 384(16):1503-1516. PubMed ID: 33631066
[TBL] [Abstract][Full Text] [Related]
19. Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial.
Rosas IO; Diaz G; Gottlieb RL; Lobo SM; Robinson P; Hunter BD; Cavalcante AW; Overcash JS; Hanania NA; Skarbnik A; Garcia-Diaz J; Gordeev I; Carratalà J; Gordon O; Graham E; Lewin-Koh N; Tsai L; Tuckwell K; Cao H; Brainard D; Olsson JK
Intensive Care Med; 2021 Nov; 47(11):1258-1270. PubMed ID: 34609549
[TBL] [Abstract][Full Text] [Related]
20. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
RECOVERY Collaborative Group
Lancet; 2021 May; 397(10285):1637-1645. PubMed ID: 33933206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
